Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • 17 Priming of tumour or HIV-sp...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
17 Priming of tumour or HIV-specific human CD8+ T cells with superior functional properties using STING ligands

17 Priming of tumour or HIV-specific human CD8+ T cells with superior functional properties using STING ligands

Bibliographic Details
Main Authors: Laura Papagno, Francesco Nicoli, Nozomi Kuse, Alice Gutjahr, Gerard Tiraby, Bernard Verrier, Stéphane Paul, Masafumi Takiguchi, Victor Appay
Format: Article
Language:English
Published: Elsevier 2017-07-01
Series:Journal of Virus Eradication
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020307226
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2055664020307226

Similar Items

  • Priming of HIV-1-specific CD8+ T cells with strong functional properties from naïve T cellsResearch in context
    by: Nozomi Kuse, et al.
    Published: (2019-04-01)
  • Ligand-induced Ordering of the C-terminal Tail Primes STING for Phosphorylation by TBK1
    by: Yuko Tsuchiya, et al.
    Published: (2016-07-01)
  • STING expression and response to treatment with STING ligands in premalignant and malignant disease.
    by: Jason R Baird, et al.
    Published: (2017-01-01)
  • Correction: STING expression and response to treatment with STING ligands in premalignant and malignant disease.
    by: Jason R Baird, et al.
    Published: (2018-01-01)
  • New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses
    by: Alice Gutjahr, et al.
    Published: (2020-08-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...